Literature DB >> 20414089

Expert opinions of the first italian consensus conference on the management of malignant pleural mesothelioma.

Carmine Pinto1, Andrea Ardizzoni, Pier Giacomo Betta, Francesco Facciolo, Gianfranco Tassi, Sandro Tonoli, Maurizio Zompatori, Gabriele Alessandrini, Stefano Maria Magrini, Marcello Tiseo, Vita Mutri.   

Abstract

Malignant pleural mesothelioma (MPM) is a very important public health issue. A large amount of data indicates a relationship between mesothelioma and asbestos exposure. The incidence has both considerably and constantly increased over the past 2 decades in the industrialized countries and is expected to peak in 2010-2020. In Italy, a standardized-rate incidence in 2002 among men was 2.98 per 100,000 and 0.98 per 100,000 among women, with wide differences from one region to another. Stage diagnosis and definition may be difficult. Management of patients with MPM remains complex, so an optimal treatment strategy has not yet been clearly defined. The First Italian Consensus Conference on Malignant Pleural Mesothelioma was held Bologna (Italy) in May 20, 2008. The Consensus Conference was given the patronage of the Italian scientific societies AIOM, AIRO, AIPO, SIC, SICO, SICT, SIAPEC-IAP, AIOT, GOAM, and GIME. This Consensus did not answer all of the unresolved questions in MPM management, but the Expert Opinions have nonetheless provided recommendations, presented in this report, on MPM management for clinicians and patients.

Entities:  

Mesh:

Year:  2011        PMID: 20414089     DOI: 10.1097/COC.0b013e3181d31f02

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  5 in total

1.  Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment.

Authors:  S Lorentini; M Amichetti; L Spiazzi; S Tonoli; S M Magrini; F Fellin; M Schwarz
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

2.  Clinical practice guidelines for malignant pleural mesothelioma.

Authors:  Nico van Zandwijk
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

Review 3.  Guidelines for the diagnosis and treatment of malignant pleural mesothelioma.

Authors:  Nico van Zandwijk; Christopher Clarke; Douglas Henderson; A William Musk; Kwun Fong; Anna Nowak; Robert Loneragan; Brian McCaughan; Michael Boyer; Malcolm Feigen; David Currow; Penelope Schofield; Beth Ivimey Nick Pavlakis; Jocelyn McLean; Henry Marshall; Steven Leong; Victoria Keena; Andrew Penman
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

4.  Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study.

Authors:  Annalisa Trama; Claudia Proto; Diego Signorelli; Marina C Garassino; Giuseppe Lo Russo; Monica Ganzinelli; Arsela Prelaj; Carolina Mensi; Manuela Gangemi; Valerio Gennaro; Elisabetta Chellini; Adele Caldarella; Italo F Angelillo; Valeria Ascoli; Cristiana Pascucci; Giovanna Tagliabue; Rosanna Cusimano; Francesca Bella; Fabio Falcini; Enzo Merler; Giuseppe Masanotti; Antonio Ziino; Maria Michiara; Gemma Gola; Cinzia Storchi; Lucia Mangone; Maria F Vitale; Claudia Cirilli; Rosario Tumino; Tiziana Scuderi; Anna C Fanetti; Silvano Piffer; Marcello Tiseo; Gemma Gatta; Laura Botta
Journal:  Thorac Cancer       Date:  2020-05-04       Impact factor: 3.500

5.  Proton Therapy for Malignant Pleural Mesothelioma: A Three Case Series Describing the Clinical and Dosimetric Advantages of Proton-Based Therapy.

Authors:  Howard Lee; Jing Zeng; Stephen R Bowen; Ramesh Rengan
Journal:  Cureus       Date:  2017-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.